PDA Technical Report No. 27 (TR 27), titled "Pharmaceutical Package Integrity," was originally published in 1998 by the Parenteral Drug Association (PDA). It provides comprehensive guidance on evaluating the barrier qualities of pharmaceutical packaging, specifically focusing on sterile products. Report Overview
Technical Report No. 27: Pharmaceutical Package Integrity | PDA pda technical report 27 pdf
Cross-reference with USP <1207> – USP <1207> (Container-Closure Integrity Testing) supersedes some older TR 27 language. Create a gap table showing how your methods align with both. PDA Technical Report No
The report is structured to assist users in developing robust integrity assessment strategies. Major sections include: Biologics and biosimilars – Sensitive to even trace
However, I can give you a representative excerpt based on the known content of TR 27 (2006, currently reissued as TR 86 for container closure integrity). This is a synthesized piece that reflects the style and technical focus of the original:
This article provides a comprehensive overview of PDA TR 27, its historical context, its current relevance (including insights into the updated TR 86), why the PDF format remains essential, and how professionals can legitimately access this valuable resource.
In 2021, PDA released Technical Report 86 (TR 86), "Industry Challenges and Current Practices for Package Integrity Testing of Sterile Products." Some professionals mistakenly believe TR 27 is obsolete. This is incorrect.